Department of Experimental Medicine and Biochemical Sciences, University of Rome 'Tor Vergata', 00133 Rome, Italy.
Nucleic Acids Res. 2011 May;39(9):3892-902. doi: 10.1093/nar/gkr006. Epub 2011 Jan 18.
MicroRNAs (miRNAs) are potent negative regulators of gene expression involved in all aspects of cell biology. They finely modulate virtually all physiological pathways in metazoans, and are deeply implicated in all main pathologies, among which cancer. Mir-221 and miR-222, two closely related miRNAs encoded in cluster from a genomic region on chromosome X, are strongly upregulated in several forms of human tumours. In this work, we report that the ectopic modulation of NF-kB modifies miR-221/222 expression in prostate carcinoma and glioblastoma cell lines, where we had previously shown their oncogenic activity. We identify two separate distal regions upstream of miR-221/222 promoter which are bound by the NF-kB subunit p65 and drive efficient transcription in luciferase reporter assays; consistently, the site-directed mutagenesis disrupting p65 binding sites or the ectopical inhibition of NF-kB activity significantly reduce luciferase activity. In the most distal enhancer region, we also define a binding site for c-Jun, and we show that the binding of this factor cooperates with that of p65, fully accounting for the observed upregulation of miR-221/222. Thus our work uncovers an additional mechanism through which NF-kB and c-Jun, two transcription factors deeply involved in cancer onset and progression, contribute to oncogenesis, by inducing miR-221/222 transcription.
微小 RNA(miRNAs)是参与细胞生物学各个方面的基因表达的有效负调控因子。它们精细地调节后生动物几乎所有的生理途径,并深深涉及所有主要的病理学,其中包括癌症。miR-221 和 miR-222 是两个密切相关的 miRNA,它们在 X 染色体上的基因组区域的簇中编码,在几种人类肿瘤中强烈上调。在这项工作中,我们报告 NF-κB 的异位调节改变了前列腺癌和神经胶质瘤细胞系中 miR-221/222 的表达,我们之前已经证明了它们的致癌活性。我们鉴定了 miR-221/222 启动子上游的两个独立的远端区域,该区域由 NF-κB 亚基 p65 结合,并在荧光素酶报告基因检测中驱动有效的转录;一致地,破坏 p65 结合位点的定点突变或 NF-κB 活性的异位抑制显著降低了荧光素酶活性。在最远端的增强子区域,我们还定义了一个结合位点为 c-Jun,我们表明该因子的结合与 p65 的结合合作,充分解释了观察到的 miR-221/222 的上调。因此,我们的工作揭示了 NF-κB 和 c-Jun 通过诱导 miR-221/222 转录,作为两个深深涉及癌症发生和进展的转录因子,促进致癌作用的另一种机制。